lactic acid has been researched along with Hodgkin Disease in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Locatelli, SL | 1 |
| Careddu, G | 1 |
| Serio, S | 1 |
| Consonni, FM | 1 |
| Maeda, A | 1 |
| Viswanadha, S | 1 |
| Vakkalanka, S | 1 |
| Castagna, L | 1 |
| Santoro, A | 1 |
| Allavena, P | 1 |
| Sica, A | 1 |
| Carlo-Stella, C | 1 |
| Laster, BH | 1 |
| Isaacson, C | 1 |
| Perets, E | 1 |
| Msamra, M | 1 |
| Priel, E | 1 |
| Kalef-Ezra, J | 1 |
| Kost, J | 1 |
| Thakur, V | 1 |
| Sander, G | 1 |
| Rab, ST | 1 |
1 review available for lactic acid and Hodgkin Disease
| Article | Year |
|---|---|
Hodgkin's disease and lactic acidosis.
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Fatal Outcome; Hodgkin Disease; Humans; Lactic Acid; Live | 2001 |
2 other studies available for lactic acid and Hodgkin Disease
| Article | Year |
|---|---|
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
Topics: Animals; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Glycolysis; Hodgkin Dis | 2019 |
Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; DNA, Neoplasm; Drug Delivery Systems; Female; | 2015 |